Effects of resistant starch on lipid and glucose metabolism in insulin resistance
Effects of resistant starch on lipid and glucose metabolism in insulin resistance
批准号:
7820734
负责人:
Nathalie Bergeron
金额:
$52.97万
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-09-30 至 2011-08-31
关键词:
AddressAdipose tissueAffectAmylasesAmylopectinAmyloseApolipoproteinsAreaArtsBiological MarkersBiologyBiopsyBody WeightCaloriesCarbohydratesCardiovascular DiseasesChronicChronic DiseaseCorn starch preparationCrossover DesignDiabetes MellitusDietDietary ComponentDietary FormulationsDietary InterventionDigestionDoctor of PhilosophyDoseDrug FormulationsDyslipidemiasEnzymesEpidemicFastingFatty acid glycerol estersFoodGene ExpressionGenesGlucoseGrantGuidelinesHealthHeparinHigh Density Lipoprotein CholesterolHumanHypertriglyceridemiaIndividualInsulinInsulin ResistanceIntakeLDL Cholesterol LipoproteinsLipidsLipoproteinsLow-Density LipoproteinsMacronutrients NutritionMeasuresMediatingMetabolicMetabolic ControlMetabolic DiseasesMetabolic PathwayNon-Insulin-Dependent Diabetes MellitusObesityOutcomePhenotypePhysiologicalPlasmaPrevalencePreventionPrevention strategyProcessPropertyProtocols documentationRandomizedRecommendationRegulationReportingResistanceRoleSourceStarchTestingTranslational ResearchTriglyceridesWeightWomanabsorptionblood lipidcardiovascular disorder preventioncardiovascular disorder riskdesaturasediacylglycerol O-acyltransferaseglucose metabolismglycemic controlgraduate studenthepatic lipaseimprovedinsulin sensitivityion mobilitylipid biosynthesislipoprotein lipasemenparticleprofessorpublic health relevanceresponsesaturated fatstearoyl-coenzyme A
中文摘要
描述(由申请人提供):本申请涉及广泛的挑战领域(15)转化科学,以及特定的挑战主题15- dk -101:确定饮食中影响代谢状态的生物活性宏量营养素。肥胖患病率的惊人增长引起了人们的极大关注,因为它与许多不良健康状况有关,包括胰岛素抵抗和2型糖尿病,这与心血管疾病(CVD)风险增加有关。该项目的主要目标是确定有效的饮食策略,重点关注碳水化合物数量和淀粉消化率,以改善表达动脉粥样硬化脂蛋白表型(ALP)成分的胰岛素抵抗个体与CVD风险相关的结局变量。目前的膳食指南强调用碳水化合物卡路里替代总脂肪和饱和脂肪卡路里,以预防和控制慢性疾病。然而,我们和其他人已经表明,高碳水化合物饮食增加ALP的表达,其特征是血浆甘油三酯增加,高密度脂蛋白胆固醇降低,小而致密的低密度脂蛋白颗粒水平增加,并且这种表型可以通过适度限制碳水化合物而逆转。我们还发现,甾酰辅酶a去饱和酶(一种参与甘油三酯合成的酶)的表达随着碳水化合物的限制而减少,这种变化与血浆甘油三酯反应有关。虽然限制碳水化合物对ALP的管理是有效的,但淀粉质量的作用尚未得到解决。此外,目前还没有关于高碳水化合物和低碳水化合物饮食中抗消化淀粉和易消化淀粉的影响的研究。由于个别报道表明,抗性淀粉摄入增加可降低血浆甘油三酯和饭后胰岛素血症,我们假设淀粉质量是ALP成分的重要决定因素,这可能部分是由脂肪组织SCD表达减少介导的。本提案的目的1将通过对52名胰岛素抵抗男性和女性的控制饮食干预来解决这一假设,在高碳水化合物和低碳水化合物饮食中用抗性淀粉代替可消化淀粉后,将确定血浆脂质、脂蛋白和脂质基因表达的变化。在Aim 2中,将测量抵抗性和可消化性淀粉餐对空腹和餐后葡萄糖和胰岛素的反应,以验证淀粉消化率通过与饮食引起的血浆脂质和脂蛋白变化有关的方式改善血糖和胰岛素控制的假设。最终,了解抗性和快速消化淀粉改善胰岛素和脂质控制的机制可能有助于制定更具体的饮食建议,旨在预防和治疗胰岛素抵抗,及其相关的动脉粥样硬化性血脂异常和心血管疾病风险。
英文摘要
DESCRIPTION (provided by applicant): This application addresses the broad Challenge Area (15) Translational Science, and specific Challenge Topic 15-DK-101: Identification of bioactive macronutrients in the diet that impact metabolic state. The alarming increase in the prevalence of obesity is a cause of great concern given its association with many adverse health conditions, including insulin resistance and type 2 diabetes, which are associated with increased cardiovascular disease (CVD) risk. The primary objective of this project is to identify effective dietary strategies, focused on carbohydrate quantity and starch digestibility, to improve outcome variables associated with CVD risk in insulin resistant individuals who express components of the atherogenic lipoprotein phenotype (ALP). Current dietary guidelines emphasize substitution of carbohydrate calories for total and saturated fat calories for prevention and management of chronic disease. Yet, we and others have shown that high-carbohydrate diets increase the expression of the ALP, characterized by increased plasma triglycerides, reduced HDL cholesterol, and increased levels of small, dense LDL particles, and that this phenotype is reversed by moderate carbohydrate restriction. We have also shown that expression of steroyl coenzymeA desaturase (SCD), an enzyme involved in triglyceride synthesis, is reduced with carbohydrate restriction and that this change is correlated with plasma triglyceride response. While carbohydrate restriction is effective for management of ALP, the role of starch quality has not been addressed. Furthermore, there has been no study of the effects of resistant vs. digestible starches incorporated into high- vs. lower carbohydrate diets. Since isolated reports suggest that increased intake of resistant starch lowers plasma triglycerides and postprandial insulinemia, we hypothesize that starch quality is an important determinant of components of ALP, and that this may be mediated in part by reduced adipose tissue SCD expression. Aim 1 of this proposal will address this hypothesis by a controlled dietary intervention in 52 insulin resistant men and women in which changes in plasma lipids, lipoproteins and lipogenic gene expression will be determined after substituting resistant starch for digestible starch in a high- vs. lower-carbohydrate diet. In Aim 2, the fasting and postprandial glucose and insulin responses to a resistant vs. digestible starch meal will be measured to test the hypothesis that starch digestibility improves glycemic and insulinemic control in a way that relates to diet-induced changes in plasma lipids and lipoproteins. Ultimately, understanding the mechanisms by which resistant vs. rapidly digested starches improve insulinemic and lipid control may facilitate the formulation of more specific dietary recommendations aimed at prevention and treatment of insulin resistance, and its associated atherogenic dyslipidemia and CVD risk.
PUBLIC HEALTH RELEVANCE: The overall objective of this project is to test the capacity of a specific dietary component, resistant starch, to improve metabolic biomarkers of CVD risk in individuals who are predisposed to type 2 diabetes by virtue of reduced insulin sensitivity. The information gained from this study could facilitate formulation of dietary recommendations for CVD prevention and management that focus on carbohydrate quality as well as quantity
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Saturated Fat and Protein Effects on Atherogenic Dyslipidemia
-
批准号:8469346
-
项目类别:
-
资助金额:$143.63万
-
财政年份:2011
-
负责人:Nathalie Bergeron
-
依托单位:
Saturated Fat and Protein Effects on Atherogenic Dyslipidemia
-
批准号:8676907
-
项目类别:
-
资助金额:$147.53万
-
财政年份:2011
-
负责人:Nathalie Bergeron
-
依托单位:
Saturated Fat and Protein Effects on Atherogenic Dyslipidemia
-
批准号:8508496
-
项目类别:
-
资助金额:$20.0万
-
财政年份:2011
-
负责人:Nathalie Bergeron
-
依托单位:
Saturated Fat and Protein Effects on Atherogenic Dyslipidemia
-
批准号:8186341
-
项目类别:
-
资助金额:$145.74万
-
财政年份:2011
-
负责人:Nathalie Bergeron
-
依托单位:
Saturated Fat and Protein Effects on Atherogenic Dyslipidemia
-
批准号:8321483
-
项目类别:
-
资助金额:$150.41万
-
财政年份:2011
-
负责人:Nathalie Bergeron
-
依托单位:
Saturated Fat and Protein Effects on Atherogenic Dyslipidemia
-
批准号:8916986
-
项目类别:
-
资助金额:$16.97万
-
财政年份:2011
-
负责人:Nathalie Bergeron
-
依托单位:
Effects of resistant starch on lipid and glucose metabolism in insulin resistance
-
批准号:7940795
-
项目类别:
-
资助金额:$46.98万
-
财政年份:2009
-
负责人:Nathalie Bergeron
-
依托单位:
海外基金